Market space and technical barriers are often the two major points in dispute in the market for point-of-care testing (POCT). The poct medical market space is significantly higher than market expectations, and technical barriers are constantly increasing.
1. The internationalization of POCT Point of Care Testing: The global testing volume of COVID-19 exceeds expectations, and the daily testing volume still maintains a fluctuating upward trend. Manufacturers' overseas orders have maintained a good momentum, and overseas market expansion has accelerated.
In 2020, the overseas export business of COVID-19 has brought considerable performance flexibility to relevant manufacturers. Previously, the market expected that the volume of COVID-19 testing in 2021 might decline with the inflection point of the pandemic. But the actual situation is: from January to April 2021, it is observed that the popularity of COVID-19 testing has not diminished, while on the contrary, there is a trend of further improvement.
According to OWID data, from the beginning of 2021 to April 20, the total testing volume in the sample country has reached 721 million people, which has reached the level of 76% of last year's annual testing volume (947.1 million people), and the monthly testing volume is still increasing.
The COVID-19 testing business is an excellent opportunity for China's poct medical leader to open up overseas markets, which is conducive to attracting more overseas new customers and accelerating the process of internationalization.
2. Consumerization of poct medical: COVID-19 home testing products are in short supply overseas, showing the attributes of consumer products such as universalization, strong channel accessibility, strong public willingness to buy, and high demand frequency.
Family, community and self-inspection scenarios are among the existing scenarios in the poct devices industry. According to data from BIS Research, in the global poct medical market in 2018, the market segment of home testing accounted for approximately 22%, and this number is expected to continue to increase.
In addition, there has been an iterative trend of products guided by the needs of daily life health management in the industry. Through the combination of traditional products and a new generation of digital and intelligent equipment and software, a complete family health management ecosystem has been built, which can be used in daily life to provide protection for the health of the public in real time.
Nowadays, some European countries (Switzerland, France, Germany, the United Kingdom, etc.) have rapidly increased demand for home-based poct devices. Once the products are launched, they will quickly face short supply. Sales channels are further expanded from pharmacies to supermarkets. The British government encourages all people every week to perform two virus testings.
3. Innovation of poct medical: technology paths and platforms of poct devices continue to diversify, and new technologies and new scenarios will jointly create new growth points for the industry.
In the past, poct was more used for technology platforms such as colloidal gold and immunofluorescence. At present, the application of poct devices is evolving to high-end fields such as chemiluminescence, molecular diagnosis, and pathology.
With the maturity of technologies such as isothermal amplification and signal amplification, the application and expansion of poct medical in new areas will be further accelerated. At the same time, the development of new technologies such as microfluidic chip technology, microarray protein biochips, and magnetic immune technology will also drive the development of poct to achieve the level of precision, intelligence, and high throughput. It will play a huge role in precision medicine, hierarchical medicine, telemedicine and mobile medicine.